Peripheral neuropathy decisions — 2025

The veteran was granted a 10% disability rating for hypertension. The claim for a higher rating for bilateral hearing loss was dismissed because it was withdrawn. Service connection for skin and neuropathy disabilities is remanded for further evaluation.

The Board denied service connection for diabetes mellitus, type II, prostate cancer, erectile dysfunction, and diabetic peripheral neuropathy in all extremities due to lack of evidence linking these conditions to the veteran's service.

Service connection for hyperkalemia is denied. All other issues are remanded for further evaluation.

The Board remanded the veteran's claims for service connection of coronary artery disease, myocardial infarction, and peripheral neuropathy in both lower extremities due to herbicide exposure. The Board will consider new evidence submitted within 90 days following a hearing.

The Board denied the veteran's claims for higher disability ratings and special monthly compensation for diabetic peripheral neuropathy in all four extremities.

The veteran's rating for left lower extremity peripheral neuropathy was restored to 40% effective December 1, 2022. However, the claim for total disability based on individual unemployability (TDIU) was denied.

The Veteran's claims for a higher rating for mental health issues and eye condition were denied. Claims for service connection for peripheral neuropathy and sleep apnea were remanded.

The Board remanded the claims for increased ratings for peripheral neuropathy of both lower extremities. The Veteran will undergo a new VA examination to determine the nature and severity of his condition.

The Board remanded the veteran's claims for service connection of peripheral neuropathy in all four extremities. The VA must obtain medical examinations and opinions to assess the nature and etiology of the claimed conditions.

The Board has remanded the claims for service connection for neuropathy and gout of the bilateral lower extremities due to inadequate opinions regarding herbicide exposure during active duty in Thailand.

The Veteran's claims for service connection for colon cancer, lung cancer, peripheral neuropathy of the bilateral hands, legs, and feet, and tinnitus have all been denied. The claim for an initial rating in excess of 10 percent for tinnitus is also denied. The issue of service connection for vertigo has been remanded.

The Veteran's claims for service connection for erectile dysfunction, headaches, and sleep apnea have been raised by the record.,The Board has remanded these issues to allow for further development.

The Board remanded the veteran's claims for higher disability ratings and earlier effective dates due to insufficient medical evidence and VA's duty to assist.

The veteran's attorney is eligible for direct payment of fees based on past due benefits awarded from a March 2023 decision that granted service connection for diabetes and bilateral lower extremity diabetic neuropathy.

The Board denied the veteran's claim for an initial rating greater than 20 percent for complex regional pain syndrome with peripheral neuropathy in the right lower extremity. The evidence did not show moderately severe or complete paralysis of the nerves involved.

The Board remanded all issues to further develop whether the Veteran was exposed to PFAS during his service, which could influence his claims for service connection.

The Board remanded the veteran's claims for service connection for diabetes mellitus type II, bilateral hearing loss, and tinnitus. The Board needs more medical opinions to determine if these conditions are related to military service.

The Board remanded the claim for service connection of a right elbow disorder, including various conditions like cubital tunnel syndrome and bicep tendon tear. The Veteran's statements do not limit the scope of the claim.

The veteran's claim for service connection for chronic kidney disease was granted with an effective date of April 11, 2023. All other claims for increased disability ratings were denied due to the veteran's failure to attend scheduled VA examinations.

The veteran's effective date for service connection of diabetic peripheral neuropathy in both lower extremities was granted as June 20, 2012.